Brokerages Set UnitedHealth Group Inc (UNH) PT at $246.07

Shares of UnitedHealth Group Inc (NYSE:UNH) have been given an average rating of “Buy” by the twenty-eight brokerages that are covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and twenty-five have issued a buy recommendation on the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $245.68.

A number of analysts have issued reports on the stock. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Citigroup lifted their price target on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $260.00 to $240.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 8th.

How to Become a New Pot Stock Millionaire

In related news, insider Larry C. Renfro sold 22,184 shares of the business’s stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total transaction of $5,078,804.96. Following the transaction, the insider now owns 173,229 shares of the company’s stock, valued at $39,659,047.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction on Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the transaction, the director now directly owns 1,771,257 shares in the company, valued at approximately $397,399,220.52. The disclosure for this sale can be found here. Insiders have sold 77,015 shares of company stock worth $17,879,199 in the last ninety days. 0.89% of the stock is currently owned by insiders.

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares in the last quarter. FMR LLC boosted its stake in UnitedHealth Group by 2.1% during the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after buying an additional 1,168,324 shares in the last quarter. Geode Capital Management LLC boosted its stake in UnitedHealth Group by 4.1% during the fourth quarter. Geode Capital Management LLC now owns 9,969,166 shares of the healthcare conglomerate’s stock worth $2,193,088,000 after buying an additional 395,090 shares in the last quarter. Alliancebernstein L.P. boosted its stake in UnitedHealth Group by 1.3% during the fourth quarter. Alliancebernstein L.P. now owns 7,334,593 shares of the healthcare conglomerate’s stock worth $1,616,984,000 after buying an additional 96,727 shares in the last quarter. Finally, Jennison Associates LLC boosted its stake in UnitedHealth Group by 10.2% during the fourth quarter. Jennison Associates LLC now owns 6,107,513 shares of the healthcare conglomerate’s stock worth $1,346,462,000 after buying an additional 565,536 shares in the last quarter. 86.79% of the stock is currently owned by institutional investors and hedge funds.

NYSE UNH traded down $4.50 during trading on Friday, reaching $214.00. The company’s stock had a trading volume of 5,529,392 shares, compared to its average volume of 3,693,539. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $207,079.89, a PE ratio of 21.25, a price-to-earnings-growth ratio of 1.25 and a beta of 0.74. UnitedHealth Group has a 1-year low of $162.74 and a 1-year high of $250.79.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company earned $2.11 earnings per share. equities analysts anticipate that UnitedHealth Group will post 12.51 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Investors of record on Friday, March 9th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 29.79%.

WARNING: “Brokerages Set UnitedHealth Group Inc (UNH) PT at $246.07” was reported by WKRB News and is the property of of WKRB News. If you are accessing this piece on another website, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be read at https://www.wkrb13.com/2018/04/01/brokerages-set-unitedhealth-group-inc-unh-pt-at-246-07.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply